Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Asset Utilization Ratio (2021 - 2023)

Historic Asset Utilization Ratio for Candel Therapeutics (CADL) over the last 3 years, with Q3 2023 value amounting to 0.03.

  • Candel Therapeutics' Asset Utilization Ratio fell 259997.43% to 0.03 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.03, marking a year-over-year decrease of 259997.43%. This contributed to the annual value of 0.0 for FY2022, which is 2361.29% down from last year.
  • As of Q3 2023, Candel Therapeutics' Asset Utilization Ratio stood at 0.03, which was down 259997.43% from 0.02 recorded in Q2 2023.
  • Candel Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.0 during Q3 2021, with a 5-year trough of 0.03 in Q3 2023.
  • Its 3-year average for Asset Utilization Ratio is 0.01, with a median of 0.0 in 2022.
  • As far as peak fluctuations go, Candel Therapeutics' Asset Utilization Ratio soared by 1380.9% in 2022, and later plummeted by 259997.43% in 2023.
  • Over the past 3 years, Candel Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then increased by 13.81% to 0.0 in 2022, then crashed by 2381.11% to 0.03 in 2023.
  • Its Asset Utilization Ratio stands at 0.03 for Q3 2023, versus 0.02 for Q2 2023 and 0.01 for Q1 2023.